# Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension

> **NCT04007289** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 166 (actual)

## Conditions studied

- Intrahepatic Non Cirrhotic Portal Hypertension

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04007289
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-06-24
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04007289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04007289, "Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04007289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*